Investigation Reveals White House Role in Backroom Health Care Deal
Today, the House Energy and Commerce Subcommittee on Oversight and Investigations released new information showing the White House’s role in brokering a deal with drug makers to pass the President’s health care law. The Subcommittee has been investigating for more than a year to uncover the details of the deal made between top White House officials the Pharmaceutical Manufacturers of America (PhRMA).
Rep. Pitts’ statement follows:
“President Obama promised to make negotiations over his health care bill public. He even promised that they would air on C-SPAN. Today’s report shows that the President’s promise of transparency was broken.
“Top-level staff, including Rahm Emmanuel, were actively involved in cutting a deal with the pharmaceutical association. Yet at the time, the administration issued contradictory statements about the handshake agreement made in the White House. For good reason, they were ashamed of betraying campaign promises in such a brazen manner.”
To read the Energy and Commerce Committee staff memo, CLICK HERE.